MedPage Today on MSN
Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma
The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Objective To examine whether a multicomponent commercial fitness app with very small (‘micro’) financial incentives (FI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback